GLP-1 Collective

Policy Tracker · Patient Lens · July 4, 2026

Same Ozempic complaint, another patient's name on the filing

A fifth plaintiff joins the pile of cases arguing Novo Nordisk set list prices no one could actually afford.

5 developments affecting GLP-1 access were tracked on Friday, July 3, 2026, across 1 category. Each entry links to the full record.

## Courts and enforcement

**[Lawsuit targets Novo Nordisk's GLP-1 pricing and marketing](/lawsuits/cl-73574904)**.

**[Novo Nordisk faces lawsuit over Ozempic marketing and pricing](/lawsuits/cl-73574903)**.

**[Patient sues Novo Nordisk over GLP-1 pricing and marketing](/lawsuits/cl-73574889)**.

**[Bruner sues Novo Nordisk over GLP-1 pricing and marketing](/lawsuits/cl-73574880)**.

**[Patient sues Novo Nordisk over GLP-1 pricing and marketing](/lawsuits/cl-73574877)**.

By Amanda Bonello

Originally published by Patient Lens on GLP-1 Laws, operated by GLP-1 Studio LLC — a for-profit company founded by the Collective's Executive Director. Republished here in full, with permission, at no cost. The Collective pays nothing for it and receives no payment for publishing it. How this works.